|
AU2006252244A1
|
|
Compositions containing polyethylene glycol and uses thereof
|
|
AU4438802A
|
|
Organ preservation solution
|
|
WO9947101A2
|
|
Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
|
|
WO9919513A2
|
|
Methods for detecting compounds which modulate the activity of an lpa receptor
|
|
AU9027398A
|
|
Focusing and autofocusing in scanning laser imaging
|
|
AU9027298A
|
|
Compositions containing polyethylene glycol and uses thereof
|
|
WO9835659A1
|
|
Bak promotor expression system
|
|
AU6326198A
|
|
Organ preservation solution
|
|
US5998131A
|
|
Screening methods for the identification of compounds capable of abrogating BaK-BHRF-1 protein interactions
|
|
EP0850064A1
|
|
Compositions with anti-apoptotic activity, containing a mixture of phospholipids
|
|
AU5869296A
|
|
Wide angle scattering detector
|
|
CA2198779A1
|
|
Multi-channel acquisition using integrating sphere
|
|
AU5568396A
|
|
Methods of screening for therapeutic agents using novel apop tosis-modulating proteins
|
|
US5750360A
|
|
Method for quantitatively measuring apoptosis
|
|
US5620888A
|
|
Cell strains for use in identifying potentially therapeutically effective agents
|
|
HU9601448D0
|
|
Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
|
|
US5759548A
|
|
Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
|
|
CA2167805A1
|
|
Methods of treating apoptosis and associated conditions
|
|
EP0705435A1
|
|
A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom
|
|
AU6782494A
|
|
Methods of identifying potentially therapeutically effective agents and cell strains for use therein
|
